ArticleMolecular oncology2024

Immune checkpoint inhibitor monotherapy is sufficient to promote microenvironmental normalization via the type I interferon pathway in PD-L1-expressing head and neck cancer.

Jeon Yeob Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.